{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:52:38Z","timestamp":1649159558987},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.4065\/75.5.456","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:17:28Z","timestamp":1232759848000},"page":"456-461","source":"Crossref","is-referenced-by-count":4,"title":["Diet Drug-Related Cardiac Valve Disease: The Mayo Clinic Echocardiographic Laboratory Experience"],"prefix":"10.4065","volume":"75","author":[{"given":"Chari Y.","family":"Teramae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Fletcher A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/75.5.456_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with flenfluramine-phentermine. N1","volume":"337","author":"Connolly","year":"1997","journal-title":"Engt J Med"},{"key":"10.4065\/75.5.456_bib2","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure (o fenfluramine or dexfcnfluramine: US Department of Health and Human Services interim public health recommendations, November 1997","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal WUy Rep"},{"key":"10.4065\/75.5.456_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.75.1.175","article-title":"Color Doppler assessment of mitral r\u00e9gurgitation with orthogonal planes","volume":"75","author":"Helmcke","year":"1987","journal-title":"Circulation"},{"key":"10.4065\/75.5.456_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0735-1097(87)80254-1","article-title":"Evaluation of aortic insufficiency hy Doppler color flow mapping","volume":"9","author":"Perry","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/75.5.456_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(85)80477-0","article-title":"Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-cathetcri\/ation study in 127 patients","volume":"6","author":"Currie","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/75.5.456_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM199809103391101","article-title":"The prevalence of cardiac valvular insufficiency assessed by transthoraeic echocardiography in obese patients treated with appetite-suppressant drugs","volume":"339","author":"Khan","year":"1998","journal-title":"N Engl Med"},{"key":"10.4065\/75.5.456_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfcnfluramine, sus-taincd-rclcase dexfcnfluramine, or placebo","volume":"339","author":"Wcissman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/75.5.456_bib8","doi-asserted-by":"crossref","first-page":"7I9","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve r\u00e9gurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engt J Med"},{"key":"10.4065\/75.5.456_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic r\u00e9gurgitation (the Frammgham Heart Study)","volume":"83","author":"Singh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.4065\/75.5.456_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/hrt.70.6.537","article-title":"Primary pulmonary hypertension and fenfluramine use","volume":"70","author":"Brenot","year":"1993","journal-title":"Br Heart J"},{"key":"10.4065\/75.5.456_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bmj.293.6538.51-d","article-title":"Irreversible pulmonary hypertension after treatment with fenfluramine [letter]","volume":"293","author":"McMurray","year":"1986","journal-title":"BMJ"},{"key":"10.4065\/75.5.456_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/75.5.456_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199809103391112","article-title":"Regression of multivalvular r\u00e9gurgitation after the cessation of fenfluramine and phentermine treatment Eletterl","volume":"339","author":"Cunnistra","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/75.5.456_bib14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4065\/74.12.1191","article-title":"F-chocardiographic improvement over time after cessation of use of fenfluramine and phentermine","volume":"74","author":"Hensrud","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/75.5.456_bib15","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0735-1097(99)00445-3","article-title":"Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment","volume":"34","author":"Weissman","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/75.5.456_bib16","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1161\/01.CIR.100.21.2161","article-title":"Prevalence and determinants of valvulopathy in patients treated with dexfen-fluramine","volume":"100","author":"Shively","year":"1999","journal-title":"Circulation"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611642134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611642134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T08:50:08Z","timestamp":1545468608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611642134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0025619611642134"],"URL":"https:\/\/doi.org\/10.4065\/75.5.456","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}